Z
Zenas BioPharma, Inc. (ZBIO)
NMS – Real Time Price. Currency in USD
25.87
+1.20 (4.86%)
At close: Jun 26, 2026, 4:00 PM EDT
26.24
+0.37 (1.43%)
After-hours: Jun 26, 2026, 5:41 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NMS – Real Time Price. Currency in USD
25.87
+1.20 (4.86%)
At close: Jun 26, 2026, 4:00 PM EDT
26.24
+0.37 (1.43%)
After-hours: Jun 26, 2026, 5:41 PM EDT
No Data
There are no news for this stock.
Company's cash reserves $500.2M significantly exceed its total debt $351.7M, ensuring strong financial flexibility
Total current assets $730.2M exceed Total current liabilities $61.2M, highlighting excellent liquidity
Debt-to-equity ratio (1.0) is near the industry average, reflecting balanced leverage
Interest coverage ratio (-11.7x) is dangerously low, suggesting debt repayment risks
Negative free cash flow -$75.2M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 11.94 | 6.05 | 10 | |
| Quick ratio | 11.94 | 5.63 | 10 | |
| Debt to Equity | 1.05 | 0.30 | 6.0 | |
| Debt to Assets | 0.47 | 1.04 | 5.0 | |
| Interest coverage | -11.66 | -16.91 | 1.0 | |
| Weighted average score | 6.4 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | N/A | 50M | 5M | 10M | N/A |
| Gross Profit | -78K | 50M | 5M | 10M | -39K |
| Operating Income | -75M | -27M | -164M | -211M | -251M |
| Net Income | -119M | -37M | -157M | -378M | -425M |
| EBITDA | -75M | -27M | -164M | -211M | -251M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | 10.22 | 4.0 |
| Next quarter | N/A | -4.67 | 1.0 |
| Current year | 202.17 | 43.01 | 10 |
| Next year | 109.35 | 1.67 | 6.5 |
| Weighted average score | 5.4 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 999 | 66.32 | 67.84 | -43.46 | 7.8 |
| Y/Y | -99.99 | -141.22 | -82.49 | -102.85 | 1.0 |
| 3y average | 336.34 | -131.52 | N/A | -94.14 | 3.3 |
| 5y average | N/A | N/A | N/A | N/A | 1.0 |
| Weighted average score | 3.3 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |